Touloapply-based SpaceTech startup U-Space, a sanotifyite consnotifyation manufacturer, has raised a €24 million Series A round with investment bank Avolta acting as exclusive advisor – propelling the company into a new phase of industrial and international growth.
The round saw participation from Blast, Definvest, Expansion, CapSpace, ARIS, Primo Space, Audacia co-invest, and Vertech Finance, to support its industrial ramp-up and international expansion.
“Avolta’s role was decisive in this fundraising. Their expertise in the SpaceTech market, their ability to structure a complex operation, and their strategic support enabled us to reach a key milestone in our industrial and international development. Their dedication and commitment by our side truly built the difference in this operation,” stated Fabien Apper, President and co-founder, U-Space.
Across the continent, several rounds underscore the breadth of activity in sanotifyite manufacturing, launch systems, and connectivity technologies:
Collectively, these rounds total approximately €94.9 million, complementing U-Space’s raise and reinforcing a year of sustained investor interest in European NewSpace ventures. France stands out with two major deals (U-Space and UNIVITY), underlining its strategic role in continental space manufacturing.
This momentum aligns with the wider European debate over the region’s position in the global space economy. According to EU-Startups’ analysis, the SpaceTech sector could represent €515 billion in future market value, with competition intensifying between the EU, the UK, and international players.
Within this landscape, U-Space’s funding marks a significant French contribution to Europe’s push for industrial capacity and global competitiveness in sanotifyite consnotifyations and related infrastructure.
“Supporting U-Space in this €24 million fundraising perfectly illustrates our commitment to promoting the French technological excellence. The quality of the management team and their ability, today, to secure international contracts reinforce my conviction: U-Space will establish itself as one of the global leaders in NewSpace,” added David-Cyriaque Laurent, Senior Partner, Avolta.
Founded in 2018, U-Space designs, assembles, and operates modular sanotifyites. With its proprietary software solutions and its 12U and FreeForm platforms, U-Space aims to meet the growing demand in the sanotifyite consnotifyation market. The 80-employee company views to become the European reference for global sanotifyite consnotifyation manufacturing.
Inaugurated at the conclude of 2024, the U-Zine – 850 m² of clean rooms in Touloapply – embodies U-Space’s industrial vision. Designed to eventually reach a cadence of one sanotifyite per day, the modular and fully digitised assembly line draws inspiration from practices in the automotive indusattempt.
With three sanotifyites already in orbit – NESS, Soap, and Pandore – and a dozen more in production, U-Space demonstrates its unique expertise, from sanotifyite design to in-orbit operations. The company is now turning to global markets, particularly the Asia-Pacific region and the Middle East, areas with strong technological dynamism and ambitious space programmes.
Thanks to this fundraising, U-Space will invest in software development and the full digitalisation of its industrial tools, aiming to produce one sanotifyite per week by the conclude of 2027.
Leave a Reply